<SEC-DOCUMENT>0001601485-24-000093-index.html : 20241125
<SEC-HEADER>0001601485-24-000093.hdr.sgml : 20241125
<ACCEPTANCE-DATETIME>20241125073421
ACCESSION NUMBER:		0001601485-24-000093
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20241121
FILED AS OF DATE:		20241125
DATE AS OF CHANGE:		20241125

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			RUFFOLO ROBERT R
		CENTRAL INDEX KEY:			0001187308
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39990
		FILM NUMBER:		241491953

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Elicio Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001601485
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				113430072
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		451 D STREET, 5TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02210
		BUSINESS PHONE:		(857) 209-0050

	MAIL ADDRESS:	
		STREET 1:		451 D STREET, 5TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02210

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Angion Biomedica Corp.
		DATE OF NAME CHANGE:	20140228
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>wk-form4_1732538054.xml
<DESCRIPTION>FORM 4
<TEXT>
Document 1 - file: wk-form4_1732538054.html

Document 1 - RAW XML: wk-form4_1732538054.xml

</DOCUMENT>
</SEC-DOCUMENT>